Akebia Therapeutics, Inc. (AKBA)
Company Info
| ISIN | US00972D1054 |
|---|---|
| CUSIP | 00972D105 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $0.26 |
|---|---|
| Year Range | $0.25 - $2.93 |
| EMA (50) | $0.30 |
| EMA (200) | $0.88 |
| Average Volume | $1.27M |
| Market Capitalization | $47.83M |
AKBAShare Price Chart
Loading data...
AKBAPerformance
The chart shows the growth of $10,000 invested in Akebia Therapeutics, Inc. in Mar 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $96 for a total return of roughly -99.04%. All prices are adjusted for splits and dividends.
AKBACompare to other instruments
AKBAReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | -4.48% | 4.33% |
| 6M | -24.48% | -0.78% |
| YTD | -88.67% | -15.53% |
| 1Y | -90.82% | -14.36% |
| 5Y | -55.73% | 9.13% |
| 10Y | -41.45% | 9.22% |
AKBAMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -11.95% | 8.54% | -66.76% | -42.20% | -10.84% | -4.59% | 10.76% | -6.91% | -13.19% | -19.30% | 0.39% | |
| 2021 | 15.71% | 6.79% | -2.17% | -5.76% | 10.03% | 7.98% | -34.83% | 19.03% | -2.04% | -0.35% | -5.57% | -16.61% |
| 2020 | 14.24% | 22.85% | -14.54% | 6.86% | 43.70% | 16.67% | -17.75% | -6.80% | -75.89% | -11.55% | 49.10% | -15.41% |
| 2019 | -0.36% | 32.12% | 12.50% | -26.25% | -26.32% | 8.76% | -13.43% | -1.43% | -5.08% | -4.85% | 68.63% | 0.48% |
| 2018 | -0.61% | -3.25% | -33.36% | -3.36% | 6.62% | 1.63% | 3.21% | -20.29% | 7.55% | -15.18% | 7.88% | -31.56% |
| 2017 | -3.65% | -0.10% | -8.18% | 43.26% | 1.67% | 7.24% | -8.21% | 26.91% | 17.50% | -7.73% | -14.27% | -4.43% |
| 2016 | -43.27% | -0.41% | 23.42% | 4.22% | -5.11% | -16.05% | 19.65% | -9.16% | 11.32% | -16.91% | 14.49% | 20.91% |
| 2015 | -11.77% | -9.83% | 19.98% | -30.96% | 2.48% | 30.92% | -8.65% | -25.96% | 38.79% | -7.66% | 20.29% | 20.41% |
| 2014 | -26.73% | 24.59% | -0.29% | 14.36% | -20.33% | 1.67% | -1.69% | -41.44% | -6.79% | -3.64% |
AKBADividend History
Akebia Therapeutics, Inc. doesn't pay dividends
AKBADrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
AKBAWorst Drawdowns
The table below shows the maximum drawdowns of the Akebia Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Akebia Therapeutics, Inc. is 99.14%, recorded on Nov 17, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.14% | Jun 23, 2014 | 2119 | Nov 17, 2022 | — | — | — |
| -36.84% | Mar 21, 2014 | 16 | Apr 11, 2014 | 5 | Apr 21, 2014 | 21 |
| -21.82% | Apr 22, 2014 | 20 | May 19, 2014 | 14 | Jun 9, 2014 | 34 |
| -4.91% | Jun 10, 2014 | 6 | Jun 17, 2014 | 3 | Jun 20, 2014 | 9 |
AKBAVolatility Chart
Current Akebia Therapeutics, Inc. volatility is 47.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.